The Drug Enforcement Administration last week published an interim final rule expanding access to medication-assisted treatment under the SUPPORT for Patients and Communities Act of 2018.

Effective Oct. 30, the rule allows certain practitioners to treat more patients; permanently adds nurse practitioners and physician assistants to the definition of “qualifying other practitioner”; and permits practitioners to complete required opioid training in medical school or residency as well as post-residency.

DEA will accept comments on the rule through Jan. 4.

DEA also will accept comments through Jan. 4 on a proposed rule implementing requirements to report suspicious orders of controlled substances under the Preventing Drug Diversion Act of 2018. The rule would offer multiple options for reporting suspicious orders; establish a centralized database for reporting; define key terms; and require specific record-keeping practices.

Related News Articles

Headline
President Trump yesterday signed into law AHA-supported legislation that repeals the McCarran-Ferguson antitrust exemption available to commercial health…
Headline
Health care providers can now apply online for Section 1135 waivers related to the COVID-19 pandemic or other public health emergencies, the Centers for…
Headline
The AHA today provided comments to the Centers for Medicare & Medicaid Services’ proposed changes to the hospital and hospital health care complex cost…
Headline
UnitedHealthcare has suspended through the end of this month certain prior authorization requirements for in-network hospitals and skilled nursing facilities…
Headline
Under a final rule released today, the Department of Health and Human Services must periodically assess each regulation to determine whether it has a…
Headline
The Centers for Medicare & Medicaid Services has recalculated the Medicare Physician Fee Schedule payment rates and conversion factor for calendar…